Article Information
History
- January 22, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Narjis Boukli1,
- Claude Flamand2,
- Kim Lay Chea1,
- Leangyi Heng1,
- Seangmai Keo1,
- Kimhoung Sour1,
- Sophea In1,
- Panha Chhim1,
- Bunthea Chhor1,
- Lomor Kruy1,
- Jelena D M Feenstra3,
- Manoj Gandhi3,
- Obiageli Okafor3,
- Camilla Ulekliev3,
- Heidi Auerswald1,
- Viseth Srey Horm1 and
- Erik A Karlsson1,*
- 1Virology Unit, National Influenza Center, WHO H5 Regional reference Laboratory, World Health Organization COVID-19 Global Referral Laboratory, Institute Pasteur du Cambodge, Phnom Penh, Cambodia
- 2Epidemiology Unit, Institute Pasteur du Cambodge, Phnom Penh, Cambodia
- 3Thermo Fisher Scientific, South San Francisco CA, United States
- ↵*Corresponding author:
Erik A. Karlsson, Ph.D., Virology Unit, Institut Pasteur du Cambodge, 5 Monivong Blvd. PO Box #983, Phnom Penh, Cambodia, Phone: +855 70 297 804, Email: ekarlsson{at}pasteur-kh.org
Posted January 22, 2023.
ONE ASSAY TO TEST THEM ALL: COMPARING MULTIPLEX ASSAYS FOR EXPANSION OF RESPIRATORY VIRUS SURVEILLANCE
